Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Solid Tumor Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03042910
What this trial is testing

Assess the Effects of Talazoparib on Cardiac Repolarization in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Pfizer 38
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07681297
What this trial is testing

Tislelizumab in Combination With Bevacizumab and Capecitabine in Advanced Solid Tumors With Evaluation in Immunotherapy-Resistant and Central Nervous System Disease

Who this might be right for
Advanced Solid Tumor CancerTriple-Negative Breast Cancer (TNBC)CNS Disease+1 more
National University Hospital, Singapore 154
Testing effectiveness (Phase 2)Looking for participantsNCT05867420
What this trial is testing

ASKG915 in Patients With Selected Advanced Solid Tumors.

Who this might be right for
Advanced Solid Tumors
AskGene Pharma, Inc. 594
Early research (Phase 1)Study completedNCT01310179
What this trial is testing

Safety Study of Adenovirus/PNP Coupled With Fludarabine Phosphate to Treat Solid Tumors

Who this might be right for
Head and Neck Cancer
PNP Therapeutics, Inc. 12
Testing effectiveness (Phase 2)Looking for participantsNCT06598007
What this trial is testing

Determine the Effect of CT3001 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultColorectal CancerPancreatic Ductal Adenocarcinoma
Crossignal Therapeutics, Inc. 78
Testing effectiveness (Phase 2)Ended earlyNCT01984892
What this trial is testing

Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC)

Who this might be right for
MelanomaSquamous Cell Carcinoma of the Head and NeckSquamous Cell Carcinoma of the Skin+3 more
Nina Bhardwaj 8
Early research (Phase 1)UnknownNCT04740398
What this trial is testing

CBP-1008 in Patients With Advanced Solid Tumor

Who this might be right for
Advanced Solid Tumor
Coherent Biopharma (Suzhou) Co., Ltd. 143
Early research (Phase 1)UnknownNCT05829057
What this trial is testing

The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1

Who this might be right for
Esophagus CancerBladder CancerLiver Cancer+2 more
Zhejiang University 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401
What this trial is testing

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

Who this might be right for
Solid TumorsCNS Tumors
Hoffmann-La Roche 69
Early research (Phase 1)UnknownNCT05989724
What this trial is testing

A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorBreast CancerPancreatic Cancer+2 more
Qurgen Inc. 150
Testing effectiveness (Phase 2)Study completedNCT04914286
What this trial is testing

GFH018 in Combination With Toripalimab in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Genfleet Therapeutics (Shanghai) Inc. 148
Early research (Phase 1)Ended earlyNCT01891669
What this trial is testing

PF-06263507 In Patients With Advanced Solid Tumors

Who this might be right for
NeoplasmsCarcinoma, Non Small Cell LungBreast Neoplasms+1 more
Pfizer 26
Early research (Phase 1)Study completedNCT06056024
What this trial is testing

Test How Well Different Doses of BI 3706674 Are Tolerated by People With Advanced Cancer in the Stomach and Oesophagus

Who this might be right for
Solid Tumor, KRAS Mutation
Boehringer Ingelheim 47
Early research (Phase 1)Study completedNCT00741403
What this trial is testing

A Open Label Phase I/II Clinical Trial to Evaluate CPI-613 in Patients With Advanced Malignancies

Who this might be right for
Advanced CancerMetastatic CancerLymphoma+2 more
Cornerstone Pharmaceuticals 39
Testing effectiveness (Phase 2)Looking for participantsNCT05487170
What this trial is testing

RNK05047 in Subjects With Advanced Solid Tumors/Diffuse Large B-cell Lymphoma (CHAMP-1)

Who this might be right for
Advanced Solid TumorDLBCL
Ranok Therapeutics (Hangzhou) Co., Ltd. 32
Early research (Phase 1)Study completedNCT01012102
What this trial is testing

EMD 640 744 in Montanide ISA 51 VG Administered in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Merck KGaA, Darmstadt, Germany 104
Early research (Phase 1)Looking for participantsNCT05614739
What this trial is testing

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

Who this might be right for
Urinary Bladder NeoplasmsNeoplasm MetastasisUreteral Neoplasms
Eli Lilly and Company 677
Testing effectiveness (Phase 2)Active Not RecruitingNCT06237881
What this trial is testing

KSQ-001EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate the SOCS1 Gene, in Patients With Select Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMelanomaLung Neoplasms+1 more
M.D. Anderson Cancer Center 15
Early research (Phase 1)Active Not RecruitingNCT04606381
What this trial is testing

Amivantamab Subcutaneous (SC) Administration for the Treatment of Advanced Solid Malignancies

Who this might be right for
Neoplasms
Janssen Research & Development, LLC 158
Early research (Phase 1)Looking for participantsNCT07514065
What this trial is testing

TSL2109 Capsules in Advanced Solid Tumor Patients: Safety, Tolerability, PK and Preliminary Efficacy

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer Patients
Tasly Pharmaceutical Group Co., Ltd 78
Next Page